Extensively Drug-Resistant Typhoid Fever in the United States. (16th November 2021)

• Record Type: Journal Article
• Authors: Hughes, Michael J; Birhane, Meseret G; Dorough, Layne; Reynolds, Jared L; Caidi, Hayat; Tagg, Kaitlin A; Snyder, Caroline M; Yu, Alexander T; Altman, Shana M; Boyle, Michelle M; Thomas, Deepam; Robbins, Amy E; Waechter, HaeNa A; Cody, Irina; Mintz, Eric D; Gutelius, Bruce; Langley, Gayle; Francois Watkins, Louise K
• Is Part Of: Open forum infectious diseases. Volume 8:Number 12(2021)
• Publication Date: 2021-11-16
• Subjects: drug resistance -- microbial -- enteric fever -- Salmonella Typhi infection -- treatment -- Pakistan; Communicable diseases -- Periodicals; Medical microbiology -- Periodicals; Infection -- Periodicals; 616.9
• DOI: 10.1093/ofid/ofab572
• Languages: English
• ISSNs: 2328-8957

Abstract

Abstract: Cases of extensively drug-resistant (XDR) typhoid fever have been reported in the United States among patients who did not travel internationally. Clinicians should consider if and where the patient traveled when selecting empiric treatment for typhoid fever. XDR typhoid fever should be treated with a carbapenem, azithromycin, or both.